认知康复与有氧运动治疗进展型多发性硬化认知障碍(CogEx):一项随机、盲法、假对照试验
CogEx是一项在6国11个中心完成的随机、假对照试验,纳入311例伴处理速度受损的进展型多发性硬化患者,比较认知康复与有氧运动单独及联合应用的疗效。12周时各组符号数字模态测验(SDMT)评分的最小二乘均值组间差异无统计学意义(p=0.85)。作者认为认知康复联合运动似乎不能改善进展型多发性硬化患者的处理速度,但所用假干预并非无活性,需与无干预组比较的研究。
要点
- 12周时各组SDMT评分的最小二乘均值组间差异无统计学意义(p=0.85)。
- 与双假对照相比,认知康复联合运动组差异为-1.30(95%CI -3.75至1.16)。
- 研究期间发生11例可能与干预相关的不良事件,分布于四个干预组。
核心结论
- 认知康复联合运动似乎不能改善进展型多发性硬化患者的处理速度;但本研究的假干预并非无活性,需要与无干预组比较的研究来探讨能否获得有临床意义的处理速度改善。
研究设计与样本
- CogEx为随机、假对照试验,在比利时、加拿大、丹麦、意大利、英国和美国的11个医院门诊、大学与康复中心完成。
- 纳入25-65岁、EDSS评分低于7、SDMT表现低于常模1.282个标准差或以上的进展型多发性硬化患者。
- 311例参与者按1:1:1:1随机分为认知康复联合运动组、认知康复联合假运动组、运动联合假认知康复组、双假对照组,干预每周2次、共12周。
- 主要结局为12周时SDMT测得的处理速度,采用线性混合模型比较各组最小二乘均值差异。
- 试验注册号ClinicalTrials.gov NCT03679468,已完成。
主要发现
- 2018年12月14日至2022年4月2日共纳入311例进展型多发性硬化患者,284例(91%)完成12周评估(男性117/311[38%],女性194/311[62%])。
- 12周时SDMT的最小二乘均值组间差异无统计学意义(p=0.85)。
- 与假认知康复联合假运动组(n=67)相比,认知康复联合运动组(n=70)差异为-1.30(95%CI -3.75至1.16)。
- 与假认知康复联合假运动组(n=67)相比,假认知康复联合运动组(n=71)差异为-2.78(95%CI -5.23至-0.33)。
- 与假认知康复联合假运动组(n=67)相比,认知康复联合假运动组(n=76)差异为-0.71(95%CI -3.11至1.70)。
局限性
- 作者的解读指出,本研究的假干预并非无活性,需要与无干预组比较的研究来探讨进展型多发性硬化患者能否获得有临床意义的处理速度改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cognitive dysfunction in people with relapsing-remitting multiple sclerosis can improve with cognitive rehabilitation or exercise. Similar effects have not been clearly shown in people with progressive multiple sclerosis. We aimed to investigate the individual and synergistic effects of cognitive rehabilitation and exercise in patients with progressive multiple sclerosis. METHODS: CogEx was a randomised, sham-controlled trial completed in 11 hospital clinics, universities, and rehabilitation centres in Belgium, Canada, Denmark, Italy, UK, and USA. Patients with progressive multiple sclerosis were eligible for inclusion if they were aged 25-65 years and had an Expanded Disability Status Scale (EDSS) score of less than 7. All had impaired processing speed defined as a performance of 1·282 SD or greater below normative data on the Symbol Digit modalities Tests (SDMT). Participants were randomly assigned (1:1:1:1), using an interactive web-response system accessed online from each centre, to cognitive rehabilitation plus exercise, cognitive rehabilitation plus sham exercise, exercise plus sham cognitive rehabilitation, or sham exercise plus sham cognitive rehabilitation. The study statistician created the randomisation sequence that was stratified by centre. Participants, outcome assessors, and investigators were blinded to group allocation. The study statistician was masked to treatment during analysis only. Interventions were conducted two times per week for 12 weeks: cognitive rehabilitation used an individualised, computer-based, incremental approach to improve processing speed; sham cognitive rehabilitation consisted of internet training provided individually; the exercise intervention involved individualised aerobic training using a recumbent arm-leg stepper; and the sham exercise involved stretching and balance tasks without inducing cardiovascular strain. The primary outcome measure was processing speed measured by SDMT at 12 weeks; least squares mean differences were compared between groups using linear mixed model in all participants who had a 12-week assessment. The trial is registered with ClinicalTrials.gov, NCT03679468, and is completed. FINDINGS: Between Dec 14, 2018, and April 2, 2022, 311 people with progressive multiple sclerosis were enrolled and 284 (91%) completed the 12-week assessment (117/311 [38%] male and 194/311 [62%] female). The least squares mean group differences in SDMT at 12 weeks did not differ between groups (p=0·85). Compared with the sham cognitive rehabilitation and sham exercise group (n=67), differences were -1·30 (95% CI -3·75 to 1·16) for the cognitive rehabilitation plus exercise group (n=70); -2·78 (-5·23 to -0·33) for the sham cognitive rehabilitation plus exercise group (n=71); and -0·71 (-3·11 to 1·70) for the cognitive rehabilitation plus sham exercise group (n=76). 11 adverse events possibly related to the interventions occurred, six in the exercise plus sham cognitive rehabilitation group (pain, dizziness, and falls), two in the cognitive rehabilitation plus sham exercise group (headache and pain), two in the cognitive rehabilitation and exercise group (increased fatigue and pain), and one in the dual sham group (fall). INTERPRETATION: Combined cognitive rehabilitation plus exercise does not seem to improve processing speed in people with progressive multiple sclerosis. However, our sham interventions were not inactive. Studies comparing interventions with a non-intervention group are needed to investigate whether clinically meaningful improvements in processing speed might be attainable in people with progressive multiple sclerosis. FUNDING: MS Canada.
引用
- Feinstein A, Amato MP, Brichetto G, et al. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial. Lancet Neurol. 2023. PMID: 37739574. doi:10.1016/S1474-4422(23)00280-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。